This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: University of South Florida, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2005-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2005-2024
Title: Denise Ratzlaff Cooper: Innovator in Stem Cell Research
Introduction
Denise Ratzlaff Cooper is a prominent inventor based in St. Petersburg, FL (US). She has made significant contributions to the field of stem cell research, particularly in the area of adipose-derived stem cells. With a total of 6 patents to her name, her work has the potential to impact medical treatments and therapies.
Latest Patents
Among her latest patents is one titled "Adipose derived stem cell exosomes and uses thereof." This patent provides exosomal compositions and exosomal lncRNA compositions, along with methods for treating wounds in subjects in need. Another notable patent is "Compositions and methods for white to beige adipogenesis," which discloses methods for converting white adipocytes to beige adipocytes, potentially aiding in obesity treatment. The compositions may include compounds such as DC677 and DC761.
Career Highlights
Denise has worked with esteemed institutions, including the University of South Florida and the United States Government as represented by the Department of Veterans Affairs. Her research has garnered attention for its innovative approaches to addressing health issues related to adipose tissue.
Collaborations
Denise has collaborated with notable colleagues, including Niketa A Patel and Lisa Gould. Their combined expertise has contributed to the advancement of research in their respective fields.
Conclusion
Denise Ratzlaff Cooper's work exemplifies the intersection of innovation and medical research. Her patents and collaborations highlight her commitment to advancing the understanding and application of stem cell technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile